Dose-Intensive Therapy With Autologous Stem Cell Transplantation for Patients With Multiple Myeloma

2004 ◽  
pp. 159-182
Author(s):  
Jean-Luc Harousseau ◽  
Michel Attal ◽  
Gary J. Schiller
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Autologous Stem Cell Transplantation ◽  
Intensive Therapy

Autologous stem cell transplantation in elderly multiple myeloma patients aged ≥65 years: a two‐centre Australian experience

2021 ◽  
Vol 51 (2) ◽  
pp. 280-283
Author(s):  
Jeremy Er ◽  
David Routledge ◽  
Jennifer Hempton ◽  
Colin Wood ◽  
Trish Joyce ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Autologous Stem Cell Transplantation ◽  
Australian Experience

scholarly journals Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma

2021 ◽  
Vol 11 (3) ◽  
Author(s):  
Kalyan Nadiminti ◽  
M. Hasib Sidiqi ◽  
Kapil Meleveedu ◽  
Hassan B. Alkhateeb ◽  
William J. Hogan ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Autologous Stem Cell Transplantation ◽  
Myeloid Neoplasms

The nutrition risk index is associated with bacteremia within 30 days after autologous stem cell transplantation in patients with multiple myeloma

2020 ◽  
Vol 22 (4) ◽  
Author(s):  
Javier Ricardo Garzón Herazo ◽  
Oscar Mauricio Muñoz Velandia ◽  
Julio Cesar Solano ◽  
Luisana Molina Pimienta ◽  
Wilmer Javier Figueroa Lemus
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Autologous Stem Cell Transplantation ◽  
Risk Index ◽  
Nutrition Risk
Sign in / Sign up

Export Citation Format

Share Document